Cencora, Inc. vs. DataMeds AI, Inc. Common Stock
Cencora, Inc. (COR) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| COR | MEDS | |
|---|---|---|
| Market Cap | $62.25 billion | $18.59 million |
| Revenue (TTM) | $638.56 million | $813,455 |
| Net Income (TTM) | $99.92 million | $-37,952,329 |
COR leads on 3 of 3 size & scale factors.
Valuation
| COR | MEDS | |
|---|---|---|
| P/E Ratio | 156.94 | — |
| Price / Book | -6349.16 | 0.29 |
| Price / Sales | 97.49 | 22.85 |
COR and MEDS split the valuation factors evenly.
Profitability
| COR | MEDS | |
|---|---|---|
| Net Margin | 15.65% | -4665.57% |
| Return on Equity | -1019.04% | -59.21% |
COR and MEDS split the profitability factors evenly.
Dividend
| COR | MEDS | |
|---|---|---|
| Dividend Yield | 0.74% | — |
| Payout Ratio | 116.50 | — |
COR and MEDS split the dividend factors evenly.
Risk & Sentiment
| COR | MEDS | |
|---|---|---|
| Short Interest | 1.46% | 0.02% |
MEDS leads on 1 of 1 risk & sentiment factors.
Dig deeper: COR overview, COR financials, MEDS overview, MEDS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.